Inovio Pharmaceuticals EPS in-line, beats on revenue

|About: Inovio Pharmaceuticals, ... (INO)|By:, SA News Editor

Inovio Pharmaceuticals (NYSEMKT:INO): Q2 EPS of -$0.19 in-line.

Revenue of $3.8M (+387.2% Y/Y) beats by $2M.